Abstract
We have identified a novel cytoskeletal protein, EPLIN (Epithelial Protein Lost In Neoplasm), that is preferentially expressed in human epithelial cells. Two EPLIN isoforms, a 600 amino acid EPLIN-α and a 759 amino acid EPLIN-β, are detected in primary epithelial cells of oral mucosa, prostate and mammary glands. The expression of EPLIN-α is either down-regulated or lost in the majority of oral cancer cell lines (8/8), prostate cancer cell lines (4/4) and xenograft tumors (3/3), and breast cancer cell lines (5/6). The amino acid sequence of EPLIN is characterized by the presence of a single centrally located LIM domain. Both EPLIN isoforms localize to filamentous actin and suppress cell proliferation when overexpressed. These findings indicate that the loss of EPLIN seen in cancer cells may play a role in cancer progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- EPLIN:
-
Epithelial protein lost in neoplasm
- MEC:
-
mammary epithelial cells
- IMEC:
-
immortalized mammary epithelial cells
- PrEC:
-
prostate epithelial cells
- NHOK:
-
normal human oral keratinocytes
References
Arber S, Halder G and Caroni P. . 1994 Cell 79: 221–231.
Baltz R, Domon C, Pillay DT and Steinmetz A. . 1992 Plant J. 2: 713–721.
Beckerle MC. . 1997 Bioessays 19: 949–957.
Brown MC, Perrotta JA and Turner CE. . 1996 J. Cell Biol. 135: 1109–1123.
Chang DD, Park, NH, Denny CT, Nelson SF and Pe M. . 1998 Oncogene 16: 1921–1930.
Dawid Ibm Breen JJ and Toyama R. . 1998 Trends in Genetics 14: 156–162.
Denizot F and Lang R. . 1986 J. Immuno. Meth. 89: 271–277.
Jurata LW and Gill GN. . 1998 Curr. Topics Micro. Immun. 228: 75–113.
Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, Brothman AR, Lamb DJ, Marcelli M, Belldegrun A, Witte ON and Sawyers CL. . 1997 Nature Medicine 4: 402–408.
Lengauer C, Kinzler KW and Vogelstein B. . 1998 Nature 396: 643–649.
Liang P and Pardee AB. . 1995 Curr. Opin. Immun. 7: 274–280.
Nagase T, Ishikawa K, Suyama M, Kikuno R, Miyajima N, Tanaka A, Kotani H, Nomura N and Ohara O. . 1998 DNA Res. 5: 277–286.
Perez-Alvarado GC, Miles C, Michelsen JW, Louis HA, Winge DR, Beckerle MC and Summers MF. . 1994 Nature Struct. Biol. 1: 388–398.
Sherr CJ. . 1998 Genes Dev. 12: 2984–2991.
Yang J, Brown MS, Ho YK and Goldstein JL. . 1995 J. Biol. Chem. 270: 12152–12161.
Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B and Kinzler KW. . 1997 Science 276: 1268–1272.
Acknowledgements
We are grateful to M Brown, D Kaetzel, M Navab, N-H Park, M Pegram, R Pietras, R Reiter, R Ross and C Sawyers for providing cell cultures and tissues used in this study. We are also grateful to C Denny, J Gasson, T Lane and M Teitell for comments on the manuscript. This work was supported by National Institutes of Health (GM58215) and Jonsson Cancer Center Foundation (Stop Cancer). RS Maul is supported by NIH Training Grant (T32CA75956).
Author information
Authors and Affiliations
Rights and permissions
This article is cited by
-
Lima1 mediates the pluripotency control of membrane dynamics and cellular metabolism
Nature Communications (2022)
-
Cell biology of mesangial cells: the third cell that maintains the glomerular capillary
Anatomical Science International (2017)
-
Combined comparative genomic hybridization and transcriptomic analyses of ovarian granulosa cell tumors point to novel candidate driver genes
BMC Cancer (2015)
-
Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2–MALT1 in MALT lymphoma
Nature Communications (2015)
-
SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization
Oncogene (2015)